Brief: Ascelia Q4 Operating Loss Widens To SEK 27.9 Mln

Ascelia Pharma AB

16/02/2021 07:04

Feb 16 (Reuters) - Ascelia Pharma AB  ACELP.ST :
    * QUARTERLY REPORT Q4 2020: MANGORAL SHOWS HIGH DIAGNOSTIC
VALUE
IN NEW STUDY
    * Q4 OPERATING RESULT OF SEK -27.9M (SEK -22.9M)

Source text for Eikon:  ID:nWkr8HWxDQ 
Further company coverage:  ACELP.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))